期刊文献+

Effects of Vasculogenic Mimicry on Postoperative Recurrence and Progression of Non-Small Cell Lung Cancer

下载PDF
导出
摘要 Vasculogenic mimicry(VM)in lung cancer shortens overall survival(OS)but its'associations with postoperative recurrence and progression of early non-small cell lung cancer(NSCLC)remain unclear.The purpose of this study was to analyze the association of VM with postoperative recurrence and progression of NSCLC as well as the effect of VM on postoperative recurrence-free survival(RFS).This study included NSCLC patients and detected VM in surgical specimens.The associations ofVM with the recurrence and progression were analyzed to assess the effect ofVM on postoperative RFS in NSCLC.A total of 80 NSCLC cases were followed up for 3 years.During follow-up,35 cases showed recurrence and progression where 5(6.25%)cases had simple local recurrence and the other 30(37.5%)cases had distant metastasis.The recurrence and progression rates in the first,second,and third years were 12.50%,23.75%,and 7.50%,respectively.The median RFS was 14.2 months.VM was detected in 30 out of 80 cases and was significantly correlated with tumor differentiation(r=0.365)and clinical stage(r=0.374)(both,P=0.001).Local recurrence of NSCLC was not correlated with VM,unlike distant metastasis(r=0.598,P<0.001).Average RFS was significantly longer in NSCLC patients without VM compared with the VM group 3 years post-operation(32 months versus 18 months,log-rank test P<0.001).Considering these,VM is significantly correlated with postoperative distant metastasis of NSCLC in which it is of a certain value for predicting poor prognosis in NSCLC.
出处 《Proceedings of Anticancer Research》 2021年第4期81-92,共12页 抗癌研究
基金 by grants from the Natural Science Foundation of Jiangsu Province of China(Number:BK20181232) Talent Project of Jiangsu Province of China(Number:BRA2020186) Talent Project of Taizhou city(Number:RCPY201833) the Major Programs of Natural Science Foundation of Higher Education in Jiangsu Province(Number:19KJA480003).
  • 相关文献

参考文献1

二级参考文献17

  • 1Riquet M, Bagan P, Le Pimpec Barthes F, et al. Completely resected nonsmall cell lung cancer: reconsidering prognostic value and significance of N2 metastases. Ann Thorac Surg, 2007, 84(6): 1818-1824.
  • 2Riquet M, Assouad J, Bagan P, et al. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Ann Thorac Surg, 2005, 79(1 ): 225-233.
  • 3Yamamoto K, Miyamoto Y, Ohsumi A, et al. Sleeve lung resection for lung cancer: Analysis according to the type of procedure. J Thorac Cardiovasc Surg, 2008, 136(5): 1349-1356.
  • 4Kang CH, Ra YJ, Kim YT, et al. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 non small-cell lung cancer. Ann Thorac Surg, 2008, 86(4): 1092-1097.
  • 5Lally BE, Zelterman D, Colasanto JM, et al. Postoperative radiotherapy for stage Ⅱ or Ⅲ non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol, 2006, 24( 19): 2998-3006.
  • 6National Cancer Institute, Surveillance, epidemiology and end results (SEER) data. http://seer.cancer.gov/, Accessed Jun S, 2008.
  • 7van Meerbeeck JP, Kramer GW, Van Schii PE, et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage ⅢA-N2 non-small-cell lung cancer. J Natl Cancer Inst, 2007, 99(6): 442-450.
  • 8Detterbeck F. What to do with "Surprise" N27: intraoperative management of patients with non-small cell lung cancer. J Thorac Oncol, 2008, 3(3): 289-302.
  • 9NCCN clinical Practice Guidelines in Oncology. www.nccn.org. Non-Small Cell Lung Cancer, V2.2009.
  • 10Mountain CF. Revisions in the international system for staging lung cancer. Chest, 1997,111(6): 1710-1717.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部